Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes
Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes
Active, not recruiting · NCT07039357 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Active, not recruiting | Not applicable | 2026-09-15 | NCT07039357 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Glyconics Ltd | 1 |
| Queen Mary University of London | 102 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barts Liver Centre | London | United Kingdom | 1 |
| Tameside and Glossop Integrated Care NHS Foundation Trust, Tameside General Hospital, Fountain Street | Ashton-under-Lyne | United Kingdom | 1 |